591P Survival and benefit of adjuvant chemotherapy (ACT) by circulating tumor DNA (ctDNA)-based genomic profile and molecular residual disease (MRD) in resectable colorectal oligometastases (CRM): PRECISION, a prospective multicenter study
Autor: | Kobayashi, S., Takamoto, T., Shiomi, A., Takahashi, A., Shiozawa, M., Shimizu, Y., Kagawa, Y., Nobuoka, D., Yamauchi, J., Kato, T., Oki, E., Taketomi, A., Takahashi, Y., Natsume, S., Niguma, T., Nakamura, Y. |
---|---|
Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S428-S429 |
Databáze: | ScienceDirect |
Externí odkaz: |